Circulation-Heart Failure

Papers
(The H4-Index of Circulation-Heart Failure is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Management of Acute Myocarditis and Chronic Inflammatory Cardiomyopathy347
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic Shock155
Understanding the Complexity of Heart Failure Risk and Treatment in Black Patients139
Lower Rates of Heart Failure and All-Cause Hospitalizations During Pulmonary Artery Pressure-Guided Therapy for Ambulatory Heart Failure124
Trends in 30- and 90-Day Readmission Rates for Heart Failure114
Multidisciplinary Cardiac Rehabilitation and Long-Term Prognosis in Patients With Heart Failure112
Cardioprotective Effects of Sirtuin-1 and Its Downstream Effectors101
Polypharmacy in Older Adults Hospitalized for Heart Failure101
Prevalence and Incidence of Heart Failure Among Urban Patients in China: A National Population-Based Analysis87
Predicting the Risk of Right Ventricular Failure in Patients Undergoing Left Ventricular Assist Device Implantation84
Ketone Ester Treatment Improves Cardiac Function and Reduces Pathologic Remodeling in Preclinical Models of Heart Failure84
Incidence of New-Onset and Worsening Heart Failure Before and After the COVID-19 Epidemic Lockdown in Denmark81
Approach to Acute Cardiovascular Complications in COVID-19 Infection81
Cardiogenic Shock and Hyperinflammatory Syndrome in Young Males With COVID-1976
Clinical Phenotypes and Prognosis of Dilated Cardiomyopathy Caused by Truncating Variants in the TTN Gene75
Sex Disparities in the Management and Outcomes of Cardiogenic Shock Complicating Acute Myocardial Infarction in the Young69
Long-Term Survival With Tafamidis in Patients With Transthyretin Amyloid Cardiomyopathy64
Intra-Aortic Balloon Pump Bridging to Heart Transplantation57
Chronically Elevating Circulating Ketones Can Reduce Cardiac Inflammation and Blunt the Development of Heart Failure56
Proteomic and Functional Studies Reveal Detyrosinated Tubulin as Treatment Target in Sarcomere Mutation-Induced Hypertrophic Cardiomyopathy55
Representation of Women Authors in International Heart Failure Guidelines and Contemporary Clinical Trials52
Secondary Impact of the COVID-19 Pandemic on Patients With Heart Failure51
Obese-Inflammatory Phenotypes in Heart Failure With Preserved Ejection Fraction48
Clinical Outcomes Associated With Acute Mechanical Circulatory Support Utilization in Heart Failure Related Cardiogenic Shock48
Inflammation and Circulating Natriuretic Peptide Levels47
Temporal Trend of Age at Diagnosis in Hypertrophic Cardiomyopathy46
Safety, Performance, and Efficacy of Cardiac Contractility Modulation Delivered by the 2-Lead Optimizer Smart System46
Study Design and Rationale of EXPLORER-HCM45
Prognostic Value of Secreted Frizzled-Related Protein 5 in Heart Failure Patients With and Without Type 2 Diabetes Mellitus44
Risk Profiles in Heart Failure44
Excess 30-Day Heart Failure Readmissions and Mortality in Black Patients Increases With Neighborhood Deprivation43
Invasive Right Ventricular Pressure-Volume Analysis: Basic Principles, Clinical Applications, and Practical Recommendations42
Epicardial Adipose Tissue and Outcome in Heart Failure With Mid-Range and Preserved Ejection Fraction40
Defining Shock and Preshock for Mortality Risk Stratification in Cardiac Intensive Care Unit Patients39
Referral Criteria to Palliative Care for Patients With Heart Failure39
Infection-Related Hospitalization in Heart Failure With Reduced Ejection Fraction37
Conceptual Considerations for Device-Based Therapy in Acute Decompensated Heart Failure37
0.025854110717773